Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1982 Jan;195(1):30–34. doi: 10.1097/00000658-198201001-00005

Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions.

C L Day Jr, M C Mihm Jr, A J Sober, M N Harris, A W Kopf, T B Fitzpatrick, R A Lew, T J Harrist, F M Golomb, A Postel, P Hennessey, S L Gumport, J W Raker, R A Malt, A B Cosimi, W C Wood, D F Roses, F Gorstein, D Rigel, R J Friedman, M M Mintzis
PMCID: PMC1352400  PMID: 7055381

Abstract

Fourteen variables were tested for their prognostic usefulness in 203 patients with clinical Stage I melanoma and primary tumor 0.76-169 mm thick. Only two variables, primary tumor location and level of invasion, were useful in predicting death from melanoma for these patients. Of the 12 deaths from melanoma, 11 occurred in patients with primary tumors located on the upper back, posterior arm, posterior neck, and posterior scalp (=BANS). There has been only one death from melanoma in 136 patients with melanoma located at other sites (11/67 vs 1/136, p less than 0.0001 Fisher's Exact Test). Of the 67 BANS patients, 51 had level II or level III lesions and five (10%0 died of melanoma. This compared with six deaths from melanoma in 16 patients (37.5%) with level IV BANS lesions (5/51 vs 6/16, p = 0.01 Fisher's Exact Test). The relatively high incidence of both melanoma deaths and regional node metastases for the BANS group merits consideration for testing the efficacy of elective regional node dissection for these patients.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balch C. M., Murad T. M., Soong S. J., Ingalls A. L., Halpern N. B., Maddox W. A. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 1978 Dec;188(6):732–742. doi: 10.1097/00000658-197812000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balch C. M., Soong S. J., Murad T. M., Ingalls A. L., Maddox W. A. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery. 1979 Aug;86(2):343–351. [PubMed] [Google Scholar]
  3. Balch C. M., Soong S. J., Murad T. M., Ingalls A. L., Maddox W. A. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg. 1981 Mar;193(3):377–388. doi: 10.1097/00000658-198103000-00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908. doi: 10.1097/00000658-197011000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
  6. Day C. L., Jr, Harrist T. J., Gorstein F., Sober A. J., Lew R. A., Friedman R. J., Pasternack B. S., Kopf A. W., Fitzpatrick T. B., Mihm M. C., Jr Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg. 1981 Jul;194(1):108–112. doi: 10.1097/00000658-198107000-00019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Day C. L., Jr, Lew R. A., Mihm M. C., Jr, Harris M. N., Kopf A. W., Sober A. J., Fitzpatrick T. B. The natural break points for primary-tumor thickness in clinical Stage I melanoma. N Engl J Med. 1981 Nov 5;305(19):1155–1155. doi: 10.1056/NEJM198111053051916. [DOI] [PubMed] [Google Scholar]
  8. Day C. L., Jr, Mihm M. C., Jr, Lew R. A., Harris M. N., Kopf A. W., Fitzpatrick T. B., Harrist T. J., Golomb F. M., Postel A., Hennessey P. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg. 1982 Jan;195(1):35–43. doi: 10.1097/00000658-198201001-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Day C. L., Jr, Sober A. J., Kopf A. W., Lew R. A., Mihm M. C., Jr, Golomb F. M., Hennessey P., Harris M. N., Gumport S. L., Raker J. W. A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery. 1981 May;89(5):599–603. [PubMed] [Google Scholar]
  10. Day C. L., Jr, Sober A. J., Kopf A. W., Lew R. A., Mihm M. C., Jr, Golomb F. M., Postel A., Hennessey P., Harris M. N., Gumport S. L. A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. Am J Surg. 1981 Aug;142(2):247–251. doi: 10.1016/0002-9610(81)90286-5. [DOI] [PubMed] [Google Scholar]
  11. Day C. L., Jr, Sober A. J., Kopf A. W., Lew R. A., Mihm M. C., Jr, Hennessey P., Golomb F. M., Harris M. N., Gumport S. L., Raker J. W. A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg. 1981 Apr;193(4):436–440. doi: 10.1097/00000658-198104000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Day C. L., Jr, Sober A. J., Lew R. A., Mihm M. C., Jr, Fitzpatrick T. B., Kopf A. W., Harris M. N., Gumport S. L., Raker J. W., Malt R. A. Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer. 1981 Mar 1;47(5):955–962. doi: 10.1002/1097-0142(19810301)47:5<955::aid-cncr2820470523>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  13. Eldh J., Boeryd B., Peterson L. E. Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis. Scand J Plast Reconstr Surg. 1978;12(3):243–255. doi: 10.3109/02844317809013000. [DOI] [PubMed] [Google Scholar]
  14. Gromet M. A., Epstein W. L., Blois M. S. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer. 1978 Nov;42(5):2282–2292. doi: 10.1002/1097-0142(197811)42:5<2282::aid-cncr2820420528>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  15. Veronesi U., Adamus J., Bandiera D. C., Brennhovd I. O., Caceres E., Cascinelli N., Claudio F., Ikonopisov R. L., Javorskj V. V., Kirov S. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med. 1977 Sep 22;297(12):627–630. doi: 10.1056/NEJM197709222971202. [DOI] [PubMed] [Google Scholar]
  16. Veronesi U., Adamus J., Bandiera D. C., Brennhovd I. O., Caceres E., Cascinelli N., Claudio F., Ikonopisov R. L., Javorskj V. V., Kirov S. Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori. 1980 Jun 30;66(3):373–396. doi: 10.1177/030089168006600311. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES